Insys to Pay $225 Million to Settle Opioid-Sales Probe
Jeff Sessions, U.S. attorney general, listens during an event on actions to combat the opioid crisis in the Great Hall at the Department of Justice in Washington, D.C., U.S. (Photographer: Andrew Harrer/Bloomberg)

Insys to Pay $225 Million to Settle Opioid-Sales Probe

(Bloomberg) -- Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle U.S. claims that the ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.